Charting the human centrosome-cilium landscape

Dr Laurence Pelletier, Lunenfeld-Tanenbaum’s Institute.

CRUK CI Lecture Theatre.

Tuesday 12 April 2016, 15:00-16:00

Role of Extracellular Metabolites in Tumor Organization

Dr Carlos Carmona-Fontaine (Memorial Sloan Kettering Cancer Center).

Cancer Research UK Cambridge Institute, Lecture Theatre.

Wednesday 22 April 2015, 13:00-14:00

**CANCELLED** The role of EGFR family receptor signaling-induced NF-kB activation in human breast cancer

Debajit Biswas, Dana-Farber Cancer Institute and Harvard Medical School.

Cancer Research UK Cambridge Research Institute, Room 215.

Wednesday 19 March 2014, 15:00-16:00

Targeted Cancer Therapy: Accomplishments and Challenges

John Mendelsohn, MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer Therapy.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Wednesday 19 March 2014, 13:00-14:00

Detecting low-concentration compounds with water sensitivity and spectroscopic specificity using CEST-MRI

Peter van Zijl, Johns Hopkins University and Kennedy Krieger Institute.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Friday 13 December 2013, 13:00-14:00

Comprehensive transcriptome and epigenome sequencing of hypoxic breast cancer reveals non-coding RNAs associated with clinicopathological features

Ioannis (Jiannis) Ragoussis, McGill University, Canada and Genome Quebec Innovation Centre.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Monday 09 December 2013, 13:00-14:00

Tumor hypoxia: developing prognostic biomarkers to predict therapeutic outcome

Ralph P. Mason, The University of Texas Southwestern Medical Center.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Friday 04 October 2013, 13:00-14:00

SMARTer cDNA Synthesis for Illumina Sequencing and iDimerize Inducible Dimerization Systems

Syed Abedi, Takara-Clontech.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Thursday 16 May 2013, 10:30-12:00

Standardising tumour tissue dissociation to increase the reliability and reproducibility of downstream analysis

Dawn Farrar, Miltenyi Biotec.

Cancer Research UK Cambridge Institute, Lecture Theatre.

Wednesday 10 April 2013, 11:00-12:00

New tools for NGS libraries: Long-Span, Mate-Pair Scaffolding and Methods for Faster Library Creation

Places are limited, please e-mail saphsa.codling@cruk.cam.ac.uk if you want to attend

David Mead, Founder and Chief Executive Officer of Lucigen .

CRUK Cambridge Institute Room 215.

Wednesday 13 March 2013, 12:30-13:30

Expansion and spread of oncogenic K-ras mutant stem cells throughout the intestinal epithelium

Hugo Snippert (Molecular Cancer Research, University Medical Center, Utrecht).

Cancer Research UK Cambridge Institute, Lecture Theatre.

Tuesday 26 February 2013, 16:00-17:00

Fundamentals and Applications of Mass Cytometry, using CyTOF

Jane Limer, DVS Sciences.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Wednesday 16 January 2013, 11:00-12:00

Molecular pathology: building the backbone of translational research and personalised medicine

Manuel Salto-Tellez, Queens's University Belfast.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 11 December 2012, 10:00-11:00

Functional heterogeneity in intestinal stem cells and cancer

Doug Winton, Cancer Research UK Cambridge Research Institute.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 13 September 2012, 11:45-12:45

Niche, signaling, and epigenetic regulation of stem cells

Linheng Li, Stowers Institute for Medical Research.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Wednesday 12 September 2012, 13:00-14:00

How mitotic spindles adapt to the presence/absence of centrosomes

Hélder Maiato, Universidade do Porto, Portugal.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 19 July 2012, 16:00-17:00

Massively multi-parameter single cell data by Mass Cytometry: the technology of its acquisition and networks for its interpretation

Scott Tanner, University of Toronto and DVS Sciences.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 03 May 2012, 15:00-16:00

The ETS transcription factor ELF5 and breast cancer phenotype

Chris Ormandy, Garvan Institute, Australia.

Cancer Research UK Cambridge Research Institute, Room 215.

Friday 20 April 2012, 15:00-16:00

Gene expression programs controlling ER-negative breast cancer phenotype

Alex Swarbrick, Garvan Institute, Australia.

Cancer Research UK Cambridge Research Institute, Room 215.

Thursday 19 April 2012, 16:15-17:15

Why 90% of novel anticancer agents are ineffective in clinical trial – and what to do about it

John Hickman, Coordinator, EU Innovative Medicines Initiative PREDECT, Paris.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Friday 24 February 2012, 09:30-10:30

Cellular senescence as both a dynamic and a static phenotype

Masashi Narita, Cambridge Research Institute.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 23 February 2012, 10:00-11:00

A STAT3‐induced metabolic switch involved in tumour transformation mediates STAT3 addiction

Valeria Poli, University of Turin.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 02 February 2012, 15:00-16:00

Novel risk biomarkers based on DNA repair for early detection and prevention of lung cancer.

Zvi Livneh, Weizmann Institute of Science.

Cancer Research UK Cambridge Research Institute, Room 215.

Monday 05 December 2011, 10:30-11:30

Drug resistance and disease progression: lessons from prostate cancer

Charles Sawyers, Memorial Sloan Kettering Cancer Centre.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 10 November 2011, 13:00-14:00

The use of cell lines – promises and pitfalls

Ian Freshney, Cancer Research UK Centre for Oncology and Applied Pharmacology, University of Glasgow.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 25 October 2011, 10:30-11:30

Regulation of tumour adaptability in endocrine resistant breast cancer

Leonie Young, Royal College of Surgeons, Dublin.

Cancer Research UK Cambridge Research Institute, Room 215a.

Tuesday 11 October 2011, 11:00-12:00

So what is the real function of chromatin?

David Bazett-Jones: Senior Scientist, The Hospital for Sick Children, Professor, Department of Biochemistry, University of Toronto.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 04 October 2011, 13:00-14:00

Translational Cancer Genomics Research

Affymetrix.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 04 October 2011, 11:00-12:00

HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 Herceptin in breast cancer

Anthony Kong, Weatherall Institute of Molecular Medicine, University of Oxford.

Cancer Research UK Cambridge Research Institute, Room 215.

Thursday 25 August 2011, 12:00-13:00

Learnings from kinase inhibitors for cancer therapy

Gideon Bollag (Senior Vice President of Research for Plexxikon Inc., California).

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Friday 01 July 2011, 16:00-17:00

Progress towards a biomarker discovery-to-development pipeline in clinical proteomics

Michael Gillette, Broad Institute of MIT and Harvard.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Monday 27 June 2011, 13:00-14:00

Metabolomic Studies of Cancer Using 13C Tracer Substrates and Model Fitting

Laszlo G Boros, Associate Professor of Paediatrics, UCLA School of Medicine, and Chief Scientist, SiDMAP LLC, Los Angeles, USA.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 02 June 2011, 17:00-18:00

Haloplex technology: a genome capture system for next generation sequencing

Olle Ericsson, Halo Genomics.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 19 May 2011, 14:30-15:30

Breast MRI by the Shutter-Speed Method: Elimination of Unnecessary Breast Biopsies

Charles S. Springer Jr, Oregon Health and Science University, USA.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 21 December 2010, 12:00-13:00

3rd Generation Sequencing Technology

Ion Torrent.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Wednesday 22 September 2010, 14:00-15:00

Translating airway gene expression into a biomarker for lung cancer

Avi Spira, School of Medicine, Boston University.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Monday 28 June 2010, 13:00-14:00

Definiens Image Analysis for Translational Research and Clinical Diagnostics

Martin Baatz, Manfred Voglmeier and Oliver Lehner - Definiens AG, Munich.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Wednesday 23 June 2010, 09:30-10:30

New RNA-Seq protocol for Illumina sequencing

Chris Streck, Illumina.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 17 June 2010, 11:30-12:30

Regulation of cell cycle progression by CDK-mediated substrate phosphorylation and ubiquitination

Boris Sarcevic, Unit Head, Cell Cycle and Cancer Unit, St Vincent's Institute, Victoria, Australia.

Cancer Research UK Cambridge Research Institute, Room 009.

Thursday 03 June 2010, 15:00-16:00

Modelling human colon cancer initiation and progression in the mouse

Professor Alan R. Clarke, Joint Head of Research, Cardiff School of Biosciences.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Monday 17 May 2010, 13:00-14:00

The patterns and temporal dynamics of genomic instability in metastatic pancreatic cancer

Peter Campbell, Wellcome Trust Sanger Institute.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Friday 14 May 2010, 10:30-11:30

The protein atlas - a dictionary of 40% of all non-redundant human proteins

Caroline Kampf, Site Director Uppsala, Human Proteome Resource program.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Thursday 29 April 2010, 11:00-12:00

Regulation of Alternative Splicing by Histone Modifications

Reini Luco, National Cancer Institute, National Institutes of Health, Bethesda.

Cancer Research UK Cambridge Research Institute, Room 215.

Friday 02 April 2010, 14:00-15:00

Developing network models of disease

Jonathan M.J. Derry, Director of Research, Sage Bionetworks, Seattle.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Monday 08 March 2010, 13:00-14:00

Non-canonical p38 stress signaling in metabolism and inflammation

Romeo Ricci, Institute of Cell Biology, ETH Zurich.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Tuesday 02 February 2010, 16:00-17:00

Investigation of human mammary stem and progenitor subpopulations from BRCA1 mutation carriers and non-carriers

Elgene Lim, The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia.

Cancer Research UK Cambridge Research Institute, Room 009.

Wednesday 17 June 2009, 15:15-16:30

Characterisation of structural variation in 24 breast cancer genomes using paired-end sequencing on the Illumina Genome Analyser

If you would like to attend, please e-mail: katrien.vanlook@cancer.org.uk

Phil Stevens, Wellcome Trust Sanger Institute.

Cancer Research UK Cambridge Research Institute, Room 215.

Wednesday 27 May 2009, 15:00-16:00

Understanding the self-renewal ability of mouse embryonic stem (ES) cells through single cell mRNA and microRNA profiling approach

Fuchou Tang, The Wellcome Trust/Cancer Research UK Gurdon Institute.

Cancer Research UK Cambridge Research Institute, Library.

Thursday 13 March 2008, 12:00-13:00

Functional Heterogeneity of Mouse Hematopoietic Stem Cells

Brad Dykstra, University Medical Center Groningen, The Netherlands.

Cancer Research UK Cambridge Research Institute, Lecture Theatre.

Friday 07 March 2008, 12:00-13:00